Delisting risk
AZTR · AMEX · Biotechnology

Azitra (AZTR)

Develops engineered skin bacteria and proteins for dermatology, cosmetic ingredients, and biotechnology tools.

$0.1800
Pre-market+0.00 (+2.51%)
At close$0.1756(−0.62%)

Something off on this page? Send us feedback.

Next report
Nov 11, 2026
estimated · in 69 days
EPS estimate
−$0.04
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.63−$1.53−$1.20−$0.67−$1.15−$0.25−$0.17Pending
Estimate−$0.51−$1.40−$0.79−$0.37−$0.01−$0.12−$0.04
Surprise−23.5%+14.3%+15.2%−210.8%−2,400.0%−47.8%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$7.5MPending
Estimate
Surprise

History

DateEstimateReportedSurprise
Nov 2026−$0.04
Aug 2026−$0.12−$0.17−47.8%
May 2026−$0.01−$0.25−2,400.0%
Mar 2026−$0.37−$1.15−210.8%
Nov 2025−$0.79−$0.67+15.2%

The latest year is open to everyone — the 14 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Apr 2024
Nov 2023
Aug 2023
Mar 2023
Dec 2022
Sep 2022
Jun 2022
Mar 2022
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 11, 2026−$0.04
Aug 12, 2026−$0.12−$0.17−47.8%+3.7%
May 12, 2026−$0.01−$0.25−2,400.0%−1.5%
Mar 2, 2026−$0.37−$1.15−210.8%+6.0%
Nov 12, 2025−$0.79−$0.67+15.2%−14.6%

The latest year is open to everyone — the 14 quarters behind it read with an account.

Sign in
Aug 11, 2025
May 13, 2025
Mar 21, 2025
Nov 12, 2024
Aug 12, 2024
May 9, 2024
Apr 29, 2024
Nov 14, 2023
Aug 14, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022